Himalaya Drug Company Private Limited - Company Profile

It is a pharma private limited company based in Nelamangala, Karnataka, India, established in 1997.

1997 Nelamangala, Karnataka, India Active

Last Updated: December 22, 2025

About Himalaya Drug Company Private Limited

Himalaya Drug Company Private Limited, a active private limited company, was established on 21 May 1997 in Nelamangala, Karnataka, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24232KA1997PTC022261. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Jayashree Ullal (Director), Karagadde Ganapathi Umesh (Director), Syed Farooq Ahmed (Director). Past directors included Meraj Alim Manal, Karagadde Ganapathi Umesh, Philipe Joseph Haydon. It holds ₹161.61 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Makali, Tumkur Road, Nelamangala, Karnataka, 562162.

Company Details

CIN/LLPIN
U24232KA1997PTC022261
Registration Number
022261
Incorporation Date
21 May 1997
Authorized Capital
₹5.00 M
Paid-Up Capital
₹1.00 M
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 5.00 M as on 22-12-2025
Paid Up Capital ₹ 1.00 M as on 22-12-2025
Company Age 28 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 161.61 Cr as on 22-12-2025
Revenue Growth **** 0.34% (FY 2023)
Profit Growth **** -0.31% (FY 2023)
Ebitda **** -36.70% (FY 2023)
Net Worth 23.70% (FY 2023)
Total Assets **** 23.73% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Himalaya Drug Company Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Himalaya Drug Company Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Jayashree Ullal	Director	09 Jan 2009	Current
Karagadde Ganapathi Umesh	Director	31 Aug 2020	Current
Syed Farooq Ahmed	Director	31 Oct 1997	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	14 Sep 2020	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past
Pramod Abcsdd	Director	31 Aug 2020	Past
Pramod Abcsdd	Director	-	Past
Pramod Abcsdd	Director	09 Jan 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Himalaya Drug Company.

Himalaya Drug Company Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.34% increase. The company also saw a slight decrease in profitability, with a 0.31% decrease in profit. The company's net worth Soared by an impressive increase of 23.7%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

0.34%

*******

Revenue from Operations

*******

Total Assets

*******

23.73%

*******

Profit or Loss

*******

-0.31%

*******

Net Worth

*******

23.70%

*******

EBITDA

*******

-36.70%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Himalaya Drug Company?

In 2023, Himalaya Drug Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,616,071,435.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Union Bank Of India : 161.61 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Mar 2006	Union Bank Of India	₹161.61 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Himalaya Drug Company?

Unlock and access historical data on people associated with Himalaya Drug Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Himalaya Drug Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himalaya Drug Company's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Himalaya Drug Company

Recent Activity within the Organization

Annual General Meeting

Progress on Himalaya Drug Company Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Balance Sheet

Himalaya Drug Company Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
31 Mar 2025
Director Appointment

The activity Karagadde Ganapathi Umesh was appointed as a Director was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 6 months . was completed.
31 Aug 2020
Charges

The activity A charge with Union Bank Of India of Rs. 1,616.07 M registered on 27 Mar 2006 with Charge ID 10043583 was modified on 21 Sep 2013. was completed.
21 Sep 2013
Director Appointment

Jayashree Ullal was appointed as a Director was appointed as a Director on 09 Jan 2009 & has been associated with this company since 17 years 1 month . was recorded as a recent event.
09 Jan 2009
Charges

Progress on A charge with Union Bank Of India amounted to Rs. 1,616.07 M with Charge ID 10043583 was registered on 27 Mar 2006. was documented.
27 Mar 2006

Explore recent activity and updates - View Recent Activity